Curofyx vs Rater8

Rater8 is a well-established reputation management platform built specifically for US healthcare organisations. It combines review monitoring, AI-assisted reply drafting, automated review requests triggered through direct EHR and practice-management system integrations, and add-on modules for patient and employee satisfaction surveys and local benchmarking. For US health systems and large group practices already running compatible EHR software, that checkout-triggered automation is a genuine strength.

Curofyx takes a different approach, built first for UK clinics and now also serving US healthcare providers. Rather than requiring an EHR/PM integration to trigger requests, Curofyx sends personalised WhatsApp review requests that staff can send to individual patients or in bulk after a visit, with automatic scheduled reminders if a patient hasn't responded. This keeps setup simple for independent clinics and smaller groups that don't run — or don't want to integrate with — a compatible practice-management system.

One of the clearest differences between the two platforms is geography. Rater8 has no published UK presence, no UK GDPR-specific workflow language, and its monitored platform list — Google, Healthgrades, Vitals, WebMD and Facebook — reflects a US-only review ecosystem. UK patients research clinics on a different set of platforms, including Trustpilot, Doctify, NHS review pages, Whatclinic and iWantGreatCare, none of which Rater8 appears to monitor.

Curofyx was built around that UK platform landscape from the start, and now extends the same multi-platform monitoring to the US-relevant platforms clinics there rely on, including Google and Facebook. For a UK clinic evaluating both tools, platform coverage alone is often the deciding factor, since a reputation tool that can't see NHS or Doctify reviews is only showing part of the picture.

Request channel is a second meaningful difference. Rater8 sends review requests by SMS and email. Curofyx leads with WhatsApp, which has very high penetration among UK patients and avoids the carrier-level SMS costs and email deliverability issues that can affect other channels. Both approaches are valid — the right choice often comes down to which channel a clinic's own patients actually use and respond to.

Pricing transparency also separates the two products. Rater8 publishes its tiers openly: a free monitoring-only tier, raVE Lite at $89 per provider per month, raVE Pro at $109 per provider per month, and a custom raVE Pro+ tier — but every paid tier carries a $250 per month account minimum, and some customers report multi-year contract terms. Curofyx publishes simple, flat monthly pricing starting at £39 per month for a single-location Clinic plan, with no account minimum and a 14-day free trial before any commitment.

Rater8's per-provider pricing model can work well for larger group practices and health systems where the $250 monthly floor is easily absorbed across many providers. For an independent clinic or a small multi-branch group, that same floor can make Rater8 disproportionately expensive relative to patient volume — one of the reasons Rater8's own marketing leans toward hospitals and group practices rather than solo or small clinics.

Both platforms offer AI-assisted review reply drafting, letting staff approve or edit a suggested response rather than writing one from scratch. This is now a fairly standard feature across the reputation-management category, and the practical difference between vendors usually comes down to how naturally the drafts read and how easily they can be customised to a practice's voice, which is worth testing directly with a trial rather than taking either vendor's word for it.

Rater8 offers patient and employee satisfaction surveys and local-market benchmarking as part of its higher-priced raVE Pro and Pro+ tiers. These are useful features for larger organisations that want structured NPS-style feedback alongside public review generation. Curofyx does not currently offer built-in satisfaction surveys or benchmarking — clinics that specifically need those features today may find Rater8's higher tiers a better fit, while clinics prioritising simple, affordable review automation may prefer Curofyx.

Multi-location reporting is available on both platforms. Curofyx includes branch-level reporting from its Growth plan onward, giving multi-branch groups visibility into which locations are performing well and which need attention from a single dashboard. Rater8's multi-location tooling is positioned toward larger group practices and health systems, consistent with its per-provider, minimum-spend pricing model.

For clinics evaluating EHR or practice-management integration specifically, Rater8's checkout-triggered automation is a real capability that Curofyx does not yet match — Curofyx review requests are sent manually or in bulk by clinic staff today, with a native appointment-linked automation on the roadmap. Clinics that already run a compatible EHR and want requests to fire automatically the moment a visit is marked complete, with no staff action required, should weigh that difference carefully.

Choosing between Curofyx and Rater8 often comes down to two questions: does the clinic operate in the UK (where Rater8 has no presence and doesn't monitor the platforms UK patients actually use), and does the clinic run an EHR system that benefits from Rater8's checkout-triggered automation today. UK clinics, and US clinics that want simpler, staff-controlled review requests without a $250 monthly floor, are generally better served by Curofyx.

Reputation management software should ultimately make it easier for a clinic's genuinely happy patients to be heard, without adding administrative burden to already-busy front-desk and clinical teams. Both Curofyx and Rater8 aim at that same goal from different starting points — Rater8 from deep US EHR integration, Curofyx from simple, WhatsApp-first requests and broad UK and US platform coverage.

Clinics comparing the two directly are best served by trialling both where possible. Curofyx offers a 14-day free trial with no credit card required, making it straightforward to test WhatsApp request delivery, platform monitoring accuracy and AI reply quality against a clinic's own patient base before committing to either platform.